ClinVar Miner

Submissions for variant NM_001267550.2(TTN):c.20236G>A (p.Ala6746Thr)

gnomAD frequency: 0.00081  dbSNP: rs202108224
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 12
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000039938 SCV000063629 likely benign not specified 2012-01-24 criteria provided, single submitter clinical testing Ala5502Thr in exon 66 of TTN: This variant is not expected to have clinical sign ificance because it has been identified in 0.4% (12/3120) of African American ch romosomes by the NHLBI Exome Sequencing Project in a broad population (http://ev s.gs.washington.edu/EVS). Ala5502Thr in exon 66 of TTN (allele frequency = 0.4% , 12/3120) **
Eurofins Ntd Llc (ga) RCV000039938 SCV000114340 likely benign not specified 2015-08-21 criteria provided, single submitter clinical testing
Invitae RCV000472656 SCV000555465 likely benign Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J 2024-01-18 criteria provided, single submitter clinical testing
Athena Diagnostics Inc RCV000039938 SCV000616016 benign not specified 2016-10-28 criteria provided, single submitter clinical testing
GeneDx RCV001703896 SCV000719941 likely benign not provided 2021-02-17 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001839532 SCV002099917 benign Autosomal recessive limb-girdle muscular dystrophy type 2J 2021-09-10 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001839533 SCV002099918 benign Myopathy, myofibrillar, 9, with early respiratory failure 2021-09-10 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001839534 SCV002099919 benign Early-onset myopathy with fatal cardiomyopathy 2021-09-10 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001839531 SCV002099920 benign Tibial muscular dystrophy 2021-09-10 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV003914967 SCV004729418 likely benign TTN-related condition 2021-01-27 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Clinical Genetics, Academic Medical Center RCV000039938 SCV001979145 benign not specified no assertion criteria provided clinical testing
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) RCV001703896 SCV001979782 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.